Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
INO-4800
INOVIO PHARMACEUTICALS, INC.
Coronavirus Infection
4 trials -
Medpulser Electroporation with Bleomycin
INOVIO PHARMACEUTICALS, INC.
Head Neck Cancer
1 trial -
VGX-3100
INOVIO PHARMACEUTICALS, INC.
Cervical Dysplasia
2 trials -
CHRONVAC-Cยฎ
INOVIO PHARMACEUTICALS, INC.
Chronic Hepatitis C Virus Infection
1 trial -
ChronVac-C + SOC
INOVIO PHARMACEUTICALS, INC.
Chronic Hepatitis C
1 trial -
GLS-5300
INOVIO PHARMACEUTICALS, INC.
Healthy
2 trials -
HPV DNA Plasmids Therapeutic Vaccine VGX-3100
INOVIO PHARMACEUTICALS, INC.
Anal Intraepithelial Neoplasia
1 trial -
INO-3107
INOVIO PHARMACEUTICALS, INC.
Respiratory Papillomatosis
1 trial -
INO-3112
INOVIO PHARMACEUTICALS, INC.
Cervical Cancer
1 trial -
INO-3112
INOVIO PHARMACEUTICALS, INC.
Head and Neck Squamous Cell Cancer
1 trial -
INO-3112 vaccine
INOVIO PHARMACEUTICALS, INC.
Uterine Cervical Neoplasms
1 trial -
INO-4700
INOVIO PHARMACEUTICALS, INC.
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
1 trial -
INO-5401
INOVIO PHARMACEUTICALS, INC.
Urothelial Carcinoma
1 trial -
INO-5401
INOVIO PHARMACEUTICALS, INC.
Glioblastoma
1 trial -
PENNVAX-GP
INOVIO PHARMACEUTICALS, INC.
HIV-1-infection
1 trial -
VGX 3100
INOVIO PHARMACEUTICALS, INC.
Cervical Intraepithelial Neoplasia
1 trial -
VGX-3100
INOVIO PHARMACEUTICALS, INC.
Anal Neoplasm
1 trial -
VGX-3100
INOVIO PHARMACEUTICALS, INC.
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1 trial -
p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine
INOVIO PHARMACEUTICALS, INC.
Leukaemia (Acute)
1 trial -
2mg INO-5150 and electroporation device CELLECTRAยฎ-5P
INOVIO PHARMACEUTICALS, INC.
Prostate Cancer
1 trial -
Electroporation-Mediated Plasmid DNA Vaccine Therapy
INOVIO PHARMACEUTICALS, INC.
Chronic Hepatitis
1 trial -
FVH1 - a DNA-based influenza vaccine
INOVIO PHARMACEUTICALS, INC.
Influenza, Human
1 trial -
GLS-5700
INOVIO PHARMACEUTICALS, INC.
Healthy
2 trials -
GLS-6150
INOVIO PHARMACEUTICALS, INC.
HCV Infection
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources